Citius Pharmaceuticals, Inc. Unrealized Gain (Loss) on Derivatives
Citius Pharmaceuticals, Inc. (CTXR) reported Unrealized Gain (Loss) on Derivatives of -$308.88 thousand for the 9-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2017-08-14
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for the quarter ending 2017-06-30 was $133.51K, a 91.01% decline year-over-year.
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for the quarter ending 2017-03-31 was $179.80K, a 9.12% decline year-over-year.
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for the quarter ending 2016-12-31 was -$622.19K.
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for the quarter ending 2016-09-30 was -$821.52K.
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for fiscal 2016 was $838.22K.
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for fiscal 2015 was -$332.10K.
- Citius Pharmaceuticals, Inc. unrealized gain (loss) on derivatives for fiscal 2014 was -$8.59K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2017-06-30 | $133.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $313.31K derived: sum of 2 quarters · filed 2017-08-14 | -$308.88K 10-Q · filed 2017-08-14 | -$1.13M derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $179.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | -$442.39K 10-Q · filed 2017-05-15 | -$1.26M derived: sum of 3 quarters · filed 2017-05-15 | $221.92K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-12-31 | -$622.19K 10-Q · filed 2017-02-14 | -$1.44M derived: sum of 2 quarters · filed 2017-02-14 | $42.13K derived: sum of 3 quarters · filed 2017-08-14 | $239.97K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-09-30 | -$821.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $664.31K derived: sum of 2 quarters · filed 2017-08-14 | $862.16K derived: sum of 3 quarters · filed 2017-08-14 | $838.22K 10-K · filed 2016-12-23 |
| 2016-06-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $1.68M derived: sum of 2 quarters · filed 2017-08-14 | $1.66M 10-Q · filed 2017-08-14 | $1.60M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $197.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $173.91K 10-Q · filed 2017-05-15 | $113.96K derived: sum of 3 quarters · filed 2017-05-15 | $165.50K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$23.94K 10-Q · filed 2017-02-14 | -$83.89K derived: sum of 2 quarters · filed 2017-02-14 | -$32.35K derived: sum of 3 quarters · filed 2017-02-14 | -$295.55K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-09-30 | -$59.95K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | -$8.41K derived: sum of 2 quarters · filed 2016-12-23 | -$271.61K derived: sum of 3 quarters · filed 2016-12-23 | -$332.10K 10-K · filed 2016-12-23 |
| 2015-06-30 | $51.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | -$211.66K derived: sum of 2 quarters · filed 2016-08-15 | -$272.15K 10-Q · filed 2016-08-15 | |
| 2015-03-31 | -$263.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | -$323.69K 10-Q · filed 2016-05-20 | ||
| 2014-12-31 | -$60.49K 10-Q · filed 2016-02-12 | |||
| 2014-09-30 | -$8.59K 10-K · filed 2015-12-14 | -$8.59K 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |